DOCSLIB.ORG

Structure of Subcomplex Iβ of Mammalian Respiratory Complex I Leads to New Supernumerary Subunit Assignments

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structure of Subcomplex Iβ of Mammalian Respiratory Complex I Leads to New Supernumerary Subunit Assignments Structure of subcomplex Iβ of mammalian respiratory complex I leads to new supernumerary subunit assignments Jiapeng Zhua, Martin S. Kinga, Minmin Yub, Liron Klipcana, Andrew G. W. Leslieb, and Judy Hirsta,1 aMedical Research Council Mitochondrial Biology Unit, Cambridge, CB2 0XY, United Kingdom; and bMedical Research Council Laboratory of Molecular Biology, Cambridge, CB2 0QH, United Kingdom Edited by Hartmut Michel, Max Planck Institute of Biophysics, Frankfurt, Germany, and approved August 14, 2015 (received for review May 29, 2015) Mitochondrial complex I (proton-pumping NADH:ubiquinone oxido- involved in regulation, homeostasis, mitochondrial biogenesis, or reductase) is an essential respiratory enzyme. Mammalian complex I protection against oxidative damage (2, 5, 7, 8). contains 45 subunits: 14 conserved “core” subunits and 31 “super- Work to determine the structure of bacterial complex I cul- numerary” subunits. The structure of Bos taurus complex I, deter- minated in the 3.3-Å resolution structure of intact Thermus mined to 5-Å resolution by electron cryomicroscopy, described the thermophilus complex I (9–11). The bacterial structures revealed structure of the mammalian core enzyme and allowed the assign- many catalytically important elements, including the flavin ment of 14 supernumerary subunits. Here, we describe the 6.8-Å mononucleotide that oxidizes NADH, the iron–sulfur (FeS) resolution X-ray crystallography structure of subcomplex Iβ,alarge clusters that transfer electrons from the flavin to ubiquinone, the portion of the membrane domain of B. taurus complex I that con- ubiquinone-binding site, and elements of the proton transfer tains two core subunits and a cohort of supernumerary subunits. By apparatus: four antiporter-like structures in the membrane, and comparing the structures and composition of subcomplex Iβ and a long transverse helix that appears to strap the membrane do- complex I, supported by comparisons with Yarrowia lipolytica com- main together. These features are closely conserved in the me- plex I, we propose assignments for eight further supernumerary dium resolution structures of the complexes from B. taurus (2) subunits in the structure. Our new assignments include two (4UQ8.pdb) and the yeast Yarrowia lipolytica (12) (4WZ7.pdb). CHCH-domain containing subunits that contain disulfide bridges be- Furthermore, in the 5-Å resolution electron cryomicroscopy tween CX9C motifs; they are processed by the Mia40 oxidative-fold- (cryo-EM) structure of the B. taurus enzyme, 18 supernumerary ing pathway in the intermembrane space and probably stabilize the transmembrane helices (TMHs) were observed, and it was pos- membrane domain. We also assign subunit B22, an LYR protein, to sible to propose assignments and partial models for 14 super- the matrix face of the membrane domain. We reveal that subunit numerary subunits (2). One of these assignments (for the 13-kDa B22 anchors an acyl carrier protein (ACP) to the complex, replicating subunit) was confirmed recently in Y. lipolytica complex I using the LYR protein–ACP structural module that was identified previ- the anomalous diffraction from a bound zinc ion (13). Currently, ously in the hydrophilic domain. Thus, we significantly extend 17 supernumerary subunits remain unassigned, and 11 super- knowledge of how the mammalian supernumerary subunits are numerary TMHs in the cryo-EM model have no subunits arranged around the core enzyme, and provide insights into their assigned to them. roles in biogenesis and regulation. Fractionation of B. taurus complex I into subcomplexes Iα,Iλ, and Iβ has provided a wealth of information on its protein CHCH domain | electron transport chain | LYR protein | mitochondria | composition, and enabled subunits to be assigned to its major NADH:ubiquinone oxidoreductase Significance n mammalian mitochondria, respiratory complex I (NADH: BIOCHEMISTRY Iubiquinone oxidoreductase) (1, 2) contains 45 subunits with a Mitochondrial complex I (proton-pumping NADH:ubiquinone – combined mass of 1 MDa (3 6). Fourteen core subunits, con- oxidoreductase) is the largest respiratory chain enzyme. Mam- served from bacteria to humans, constitute the minimal complex I malian complex I contains 45 subunits: the structures of the 14 and catalyze the energy transducing reaction: NADH oxidation “core” subunits (which are sufficient for catalysis and conserved and ubiquinone reduction coupled to proton translocation across from bacteria to humans) were described in the 5-Å resolution the inner membrane. Complex I is thus critical for mammalian structure of Bos taurus complex I, but only 14 supernumerary metabolism: it oxidizes the NADH generated by the tricarboxylic subunits could be located. Here, we exploit new structural in- β acid cycle and -oxidation, produces ubiquinol for the rest of the formation from the membrane domain of mammalian complex I respiratory chain, and contributes to the proton-motive force that to assign eight further supernumerary subunits. We locate two supports ATP synthesis and transport processes. Seven of the core oxidatively-folded CHCH-domain subunits in the intermembrane subunits are hydrophilic proteins that are encoded in the nucleus space, and reveal a second LYR protein–acyl carrier protein and imported to mitochondria, and the other seven are hydropho- module. Thus, we extend knowledge of how the supernumerary bic, membrane-bound proteins (known as the ND subunits) that are subunits are arranged around the core, and provide insights into encoded by the mitochondrial genome. These two sets of seven their roles in biogenesis and regulation. subunits form the two major domains of complex I, in the matrix and inner membrane, which confer its characteristic L shape. Author contributions: J.Z., M.S.K., and J.H. designed research; J.Z., M.S.K., and M.Y. per- The protein composition of complex I from Bos taurus heart formed research; J.Z., L.K., A.G.W.L., and J.H. analyzed data; and J.H. wrote the paper. mitochondria has been characterized extensively, and is the The authors declare no conflict of interest. blueprint for the human enzyme (3–6). In addition to the 14 core This article is a PNAS Direct Submission. subunits it contains 31 supernumerary subunits (including two Data deposition: The coordinates and structure factors for subcomplex Iβ have been de- copies of the acyl-carrier protein, SDAP; ref. 2). Several super- posited with the Protein Data Bank (accession no. 5COD). numerary subunits are homologous to proteins of known func- 1To whom correspondence should be addressed. Email: [email protected]. tion and some are required for the assembly/stability of the This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. complex, but the roles of most of them are unknown: they may be 1073/pnas.1510577112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1510577112 PNAS | September 29, 2015 | vol. 112 | no. 39 | 12087–12092 Downloaded by guest on October 2, 2021 domains (3, 5, 14). Subcomplex Iλ contains all of the redox co- (Fig. 2; note that we refer to unassigned TMHs and helices by factors and represents the hydrophilic domain; subcomplex Iα their labels in the cryo-EM structure of complex I, 4UQ8.pdb; contains subcomplex Iλ plus additional subunits from the inter- ref. 2). On the left side, two TMHs were observed on the outside domain region; and subcomplex Iβ constitutes the distal section of the transverse helix in the intact enzyme (TMHs l and m) (2) of the membrane domain. Subcomplex Iβ represents the domain of but only half of TMH l (below the transverse helix) is observed in complex I that is the least-well-characterized structurally because it the subcomplex, indicating that TMH m and the upper part of contains many unassigned supernumerary subunits (2) (Table 1). TMH l become detached from the core when the transverse helix Here, we present the 6.8-Å resolution structure of subcomplex Iβ dissociates. Two additional TMH-like densities (in red in Fig. 2) from B. taurus complex I, determined by X-ray crystallography. By are also observed in the subcomplex, and form crystal contacts comparing the structures of subcomplex Iβ and intact complex I, between molecules in the asymmetric unit (Fig. S2). They were supported by comparisons of structural elements present in the not observed in the density map of complex I (2) so may be B. taurus and Y. lipolytica complexes, we propose assignments for disordered in the intact enzyme used for cryo-EM. Alternatively, a further eight mammalian supernumerary subunits. they may be artifacts from reorganization of the structure around the dissociated transverse helix, or from the cocrystallization of Results dissociated subunits from outside of subcomplex Iβ. Two addi- The Structure of Membrane–Domain Subcomplex Iβ of Complex I. Fig. tional helices on the matrix face, and four short helices on the B. taurus β intermembrane space (IMS) face, have also been added to the 1 presents the structure of subcomplex I and the re- β lationship between subcomplex Iβ and complex I. The compo- model for subcomplex I ; they were not included in the cryo-EM sition of the crystallized subcomplex was confirmed by mass model of complex I but weak density corresponding to them is visible in the density map (2). All of the new structural elements spectrometry analyses on a sample of washed and solubilized added to the model for subcomplex Iβ are shown in red in Fig. 1B. crystals; all of the 15 expected subunits of subcomplex Iβ (5, 14) except core subunit ND4 were detected. Two core subunits, ND4 Assignments for Four TMH-Containing Subunits. The conservation of B (orange in Fig. 1 ) and the first 15 TMHs of ND5 (magenta in subunits (Table 1) (5, 8) and TMHs (Fig. 2) between complex I B Fig. 1 ), were readily identified in the electron density map and subcomplex Iβ, supported by comparisons between the (shown in Fig. S1) of the subcomplex. The C-terminal region of B. taurus (2) and Y.
Load more

Recommended publications
  • Molecular Mechanism of ACAD9 in Mitochondrial Respiratory Complex 1 Assembly
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.07.425795; this version posted January 9, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Molecular mechanism of ACAD9 in mitochondrial respiratory complex 1 assembly Chuanwu Xia1, Baoying Lou1, Zhuji Fu1, Al-Walid Mohsen2, Jerry Vockley2, and Jung-Ja P. Kim1 1Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, USA 2Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA Abstract ACAD9 belongs to the acyl-CoA dehydrogenase family, which catalyzes the α-β dehydrogenation of fatty acyl-CoA thioesters. Thus, it is involved in fatty acid β-oxidation (FAO). However, it is now known that the primary function of ACAD9 is as an essential chaperone for mitochondrial respiratory complex 1 assembly. ACAD9 interacts with ECSIT and NDUFAF1, forming the mitochondrial complex 1 assembly (MCIA) complex. Although the role of MCIA in the complex 1 assembly pathway is well studied, little is known about the molecular mechanism of the interactions among these three assembly factors. Our current studies reveal that when ECSIT interacts with ACAD9, the flavoenzyme loses the FAD cofactor and consequently loses its FAO activity, demonstrating that the two roles of ACAD9 are not compatible. ACAD9 binds to the carboxy-terminal half (C-ECSIT), and NDUFAF1 binds to the amino-terminal half of ECSIT. Although the binary complex of ACAD9 with ECSIT or with C-ECSIT is unstable and aggregates easily, the ternary complex of ACAD9-ECSIT-NDUFAF1 (i.e., the MCIA complex) is soluble and extremely stable.
    [Show full text]
  • Proteomic and Metabolomic Analyses of Mitochondrial Complex I-Deficient
    THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 24, pp. 20652–20663, June 8, 2012 © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Proteomic and Metabolomic Analyses of Mitochondrial Complex I-deficient Mouse Model Generated by Spontaneous B2 Short Interspersed Nuclear Element (SINE) Insertion into NADH Dehydrogenase (Ubiquinone) Fe-S Protein 4 (Ndufs4) Gene*□S Received for publication, November 25, 2011, and in revised form, April 5, 2012 Published, JBC Papers in Press, April 25, 2012, DOI 10.1074/jbc.M111.327601 Dillon W. Leong,a1 Jasper C. Komen,b1 Chelsee A. Hewitt,a Estelle Arnaud,c Matthew McKenzie,d Belinda Phipson,e Melanie Bahlo,e,f Adrienne Laskowski,b Sarah A. Kinkel,a,g,h Gayle M. Davey,g William R. Heath,g Anne K. Voss,a,h René P. Zahedi,i James J. Pitt,j Roman Chrast,c Albert Sickmann,i,k Michael T. Ryan,l Gordon K. Smyth,e,f,h b2 a,h,m,n3 David R. Thorburn, and Hamish S. Scott Downloaded from From the aMolecular Medicine Division, gImmunology Division, and eBioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia, the bMurdoch Childrens Research Institute, Royal Children’s Hospital and Department of Paediatrics, University of Melbourne, Parkville, Victoria 3052, Australia, the cDépartement de Génétique Médicale, Université de Lausanne, 1005 Lausanne, Switzerland, the dCentre for Reproduction and Development, Monash Institute of Medical Research, Clayton, Victoria 3168, Australia, the hDepartment of Medical Biology
    [Show full text]
  • Low Abundance of the Matrix Arm of Complex I in Mitochondria Predicts Longevity in Mice
    ARTICLE Received 24 Jan 2014 | Accepted 9 Apr 2014 | Published 12 May 2014 DOI: 10.1038/ncomms4837 OPEN Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice Satomi Miwa1, Howsun Jow2, Karen Baty3, Amy Johnson1, Rafal Czapiewski1, Gabriele Saretzki1, Achim Treumann3 & Thomas von Zglinicki1 Mitochondrial function is an important determinant of the ageing process; however, the mitochondrial properties that enable longevity are not well understood. Here we show that optimal assembly of mitochondrial complex I predicts longevity in mice. Using an unbiased high-coverage high-confidence approach, we demonstrate that electron transport chain proteins, especially the matrix arm subunits of complex I, are decreased in young long-living mice, which is associated with improved complex I assembly, higher complex I-linked state 3 oxygen consumption rates and decreased superoxide production, whereas the opposite is seen in old mice. Disruption of complex I assembly reduces oxidative metabolism with concomitant increase in mitochondrial superoxide production. This is rescued by knockdown of the mitochondrial chaperone, prohibitin. Disrupted complex I assembly causes premature senescence in primary cells. We propose that lower abundance of free catalytic complex I components supports complex I assembly, efficacy of substrate utilization and minimal ROS production, enabling enhanced longevity. 1 Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. 2 Centre for Integrated Systems Biology of Ageing and Nutrition, Newcastle University, Newcastle upon Tyne NE4 5PL, UK. 3 Newcastle University Protein and Proteome Analysis, Devonshire Building, Devonshire Terrace, Newcastle upon Tyne NE1 7RU, UK. Correspondence and requests for materials should be addressed to T.v.Z.
    [Show full text]
  • Genome-Wide Association Study of Superovulatory Response Traits in Canadian Holsteins (Preliminary Study)
    Genome-wide association study of superovulatory response traits in Canadian Holsteins (preliminary study) C. Jaton12, M. Sargolzaei13, M.K. Abo-Ismail14, F. Miglior15, C. A. Price6, A. Koeck1 and F. S. Schenkel1 1Centre for Genetic Improvement of Livestock (CGIL), University of Guelph, Guelph, Ontario, Canada, N1G 2W1, 2Centre d’insémination artificielle du Québec (Ciaq), Saint-Hyacinthe, Québec, Canada, J2S 7B8, 3Semex Alliance, Guelph, Ontario, Canada, N1G 3Z2, 4Damanhour University, Egypt, 5Canadian Dairy Network (CDN), Guelph, Ontario, Canada, N1K 1E5, 6Université de Montréal, Faculté de médecine vétérinaire, St-Hyacinthe, Québec, Canada, J2S 2M2 INTRODUCTION Superovulation and embryo transfer are frequently used in the Canadian dairy industry to produce more offspring from elite donor cows. The technical aspect of superovulation in dairy cattle has been described by many authors around the world, but the genetic and genomic aspect of this technique has still to be discovered. Superovulatory response is moderately heritable in Holstein dairy cattle (Jaton et al., 2015), so that it could be possible to genetically select donors that would produce more embryos. Moreover, finding genes that impact the superovulatory response may also help with to select of a donors that would respond well to superovulation. To our knowledge, very few studies have performed a genome-wide association study (GWAS) in dairy cattle for traits related to superovulatory response. One study performed a GWAS for fertility traits such as fertilization and blastocyst rate of Holstein cows and found significant SNPs associated with those traits (Huang et al., 2010). Another study done on Japanese black cattle identified a genetic variant in the Glutamate Receptor AMPA 1 (GRIA1) gene that has an impact on the ovulation rate (Sugimoto et al., 2010).
    [Show full text]
  • NDUFA8 (E-3): Sc-398098
    SANTA CRUZ BIOTECHNOLOGY, INC. NDUFA8 (E-3): sc-398098 BACKGROUND APPLICATIONS NDUFA8 (NDUFA8 NADH dehydrogenase (ubiquinone) 1 a subcomplex, 8), NDUFA8 (E-3) is recommended for detection of NDUFA8 of mouse, rat and also known as complex I-PGIV (CI-PGIV) or PGIV, is a 172 amino acid mitochon- human origin by Western Blotting (starting dilution 1:100, dilution range drial protein belonging to the complex I NDUFA8 subunit family. Existing as a 1:100-1:1000), immunoprecipitation [1-2 µg per 100-500 µg of total protein subunit of the multi-protein membrane respiratory chain NADH dehydrogenase (1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution complex (complex I), NDUFA8 functions as an accessory protein that facilitates range 1:50-1:500) and solid phase ELISA (starting dilution 1:30, dilution the transfer of electrons from NADH to the respiratory chain. NDUFA8 is most range 1:30-1:3000). highly expressed in heart and skeletal muscle and contains two CHCH domains. Suitable for use as control antibody for NDUFA8 siRNA (h): sc-92963, The gene encoding NDUFA8 maps to human chromosome 9, which houses over NDUFA8 siRNA (m): sc-149875, NDUFA8 shRNA Plasmid (h): sc-92963-SH, 900 genes and comprises nearly 4% of the human genome. Hereditary hemor- NDUFA8 shRNA Plasmid (m): sc-149875-SH, NDUFA8 shRNA (h) Lentiviral rhagic telangiectasia, which is characterized by harmful vascular defects, and Particles: sc-92963-V and NDUFA8 shRNA (m) Lentiviral Particles: Familial dysautonomia, are both associated with chromosome 9. sc-149875-V. REFERENCES Molecular Weight of NDUFA8: 20 kDa.
    [Show full text]
  • Human CLPB) Is a Potent Mitochondrial Protein Disaggregase That Is Inactivated By
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911016; this version posted January 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Skd3 (human CLPB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations Ryan R. Cupo1,2 and James Shorter1,2* 1Department of Biochemistry and Biophysics, 2Pharmacology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A. *Correspondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.17.911016; this version posted January 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Cells have evolved specialized protein disaggregases to reverse toxic protein aggregation and restore protein functionality. In nonmetazoan eukaryotes, the AAA+ disaggregase Hsp78 resolubilizes and reactivates proteins in mitochondria. Curiously, metazoa lack Hsp78. Hence, whether metazoan mitochondria reactivate aggregated proteins is unknown. Here, we establish that a mitochondrial AAA+ protein, Skd3 (human CLPB), couples ATP hydrolysis to protein disaggregation and reactivation. The Skd3 ankyrin-repeat domain combines with conserved AAA+ elements to enable stand-alone disaggregase activity. A mitochondrial inner-membrane protease, PARL, removes an autoinhibitory peptide from Skd3 to greatly enhance disaggregase activity. Indeed, PARL-activated Skd3 dissolves α-synuclein fibrils connected to Parkinson’s disease. Human cells lacking Skd3 exhibit reduced solubility of various mitochondrial proteins, including anti-apoptotic Hax1.
    [Show full text]
  • Skd3 (Human CLPB) Is a Potent Mitochondrial Protein Disaggregase That Is Inactivated By
    bioRxiv preprint first posted online Jan. 18, 2020; doi: http://dx.doi.org/10.1101/2020.01.17.911016. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Skd3 (human CLPB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations Ryan R. Cupo1,2 and James Shorter1,2* 1Department of Biochemistry and Biophysics, 2Pharmacology Graduate Group, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, U.S.A. *Correspondence: [email protected] 1 bioRxiv preprint first posted online Jan. 18, 2020; doi: http://dx.doi.org/10.1101/2020.01.17.911016. The copyright holder for this preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. ABSTRACT Cells have evolved specialized protein disaggregases to reverse toxic protein aggregation and restore protein functionality. In nonmetazoan eukaryotes, the AAA+ disaggregase Hsp78 resolubilizes and reactivates proteins in mitochondria. Curiously, metazoa lack Hsp78. Hence, whether metazoan mitochondria reactivate aggregated proteins is unknown. Here, we establish that a mitochondrial AAA+ protein, Skd3 (human CLPB), couples ATP hydrolysis to protein disaggregation and reactivation. The Skd3 ankyrin-repeat domain combines with conserved AAA+ elements to enable stand-alone disaggregase activity. A mitochondrial inner-membrane protease, PARL, removes an autoinhibitory peptide from Skd3 to greatly enhance disaggregase activity. Indeed, PARL-activated Skd3 dissolves α-synuclein fibrils connected to Parkinson’s disease.
    [Show full text]
  • THE FUNCTIONAL SIGNIFICANCE of MITOCHONDRIAL SUPERCOMPLEXES in C. ELEGANS by WICHIT SUTHAMMARAK Submitted in Partial Fulfillment
    THE FUNCTIONAL SIGNIFICANCE OF MITOCHONDRIAL SUPERCOMPLEXES in C. ELEGANS by WICHIT SUTHAMMARAK Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Drs. Margaret M. Sedensky & Philip G. Morgan Department of Genetics CASE WESTERN RESERVE UNIVERSITY January, 2011 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of _____________________________________________________ candidate for the ______________________degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. Dedicated to my family, my teachers and all of my beloved ones for their love and support ii ACKNOWLEDGEMENTS My advanced academic journey began 5 years ago on the opposite side of the world. I traveled to the United States from Thailand in search of a better understanding of science so that one day I can return to my homeland and apply the knowledge and experience I have gained to improve the lives of those affected by sickness and disease yet unanswered by science. Ultimately, I hoped to make the academic transition into the scholarly community by proving myself through scientific research and understanding so that I can make a meaningful contribution to both the scientific and medical communities. The following dissertation would not have been possible without the help, support, and guidance of a lot of people both near and far. I wish to thank all who have aided me in one way or another on this long yet rewarding journey. My sincerest thanks and appreciation goes to my advisors Philip Morgan and Margaret Sedensky.
    [Show full text]
  • The Dawn of the Crispr-Free Genome Editing Era
    Mitsui & Co. Global Strategic Studies Institute Monthly Report, November 2020 THE DAWN OF THE CRISPR-FREE GENOME EDITING ERA —THE DEVELOPMENT OF GENOME EDITING TECHNOLOGY— Yutaka Abe Technology Foresight Center and Industry Innovation Dept., Technology & Innovation Studies Div. Mitsui & Co. Global Strategic Studies Institute OVERVIEW The genome editing technology CRISPR-Cas9, which drew attention in the 2020 Nobel Prize in Chemistry, has been applied in various fields and has a concrete record in improving productivity and others. As such, future social implementation is expected to progress steadily. CRISPR-Cas9 has some drawbacks that need to be resolved, such as the possibility of altering the genetic information in unintended locations and the adverse effects to the organism caused by the activated immune functions due to DNA cleavage. While there are moves to improve CRISPR-Cas9 currently, research and development are underway into so- called CRISPR-free technologies, such as RNA editing technology and mitochondrial DNA editing technology that edit the genome without cutting DNA. Applications of CRISPR-free technology include RNA therapeutics and the treatment and cure of mitochondrial diseases, and these technological trends warrant attention. On October 7, 2020, the Royal Swedish Academy of Sciences announced that it would award the Nobel Prize in Chemistry to two scientists involved in the development of genome editing technology. This is a rapid award of the prize, having been just eight years since the paper1 was published in June 2012, and shows how innovative the genome editing technology CRISPR-Cas92 is. Since the effectiveness of CRISPR-Cas9 was shown in cultured cells in 2013, it has been used not only in the medical and healthcare fields but also in the areas of agriculture, livestock, and fisheries, and concrete results3 have been produced.
    [Show full text]
  • WO 2017/070647 Al 27 April 2017 (27.04.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/070647 Al 27 April 2017 (27.04.2017) P O P C T (51) International Patent Classification: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, A61K 31/455 (2006.01) C12N 15/86 (2006.01) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, A61K 31/465 (2006.01) A61P 27/02 (2006.01) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, A61K 31/19 (2006.01) A61P 27/06 (2006.01) OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, A61K 48/00 (2006.01) A61K 45/06 (2006.01) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (21) International Application Number: ZW. PCT/US2016/058388 (84) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of regional protection available): ARIPO (BW, GH, 24 October 2016 (24.10.201 6) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (25) Filing Language: English TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (26) Publication Language: English DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (30) Priority Data: LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, 62/245,467 23 October 2015 (23.
    [Show full text]
  • Influenza-Specific Effector Memory B Cells Predict Long-Lived Antibody Responses to Vaccination in Humans
    bioRxiv preprint doi: https://doi.org/10.1101/643973; this version posted February 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans Anoma Nellore1, Esther Zumaquero2, Christopher D. Scharer3, Rodney G. King2, Christopher M. Tipton4, Christopher F. Fucile5, Tian Mi3, Betty Mousseau2, John E. Bradley6, Fen Zhou2, Paul A. Goepfert1, Jeremy M. Boss3, Troy D. Randall6, Ignacio Sanz4, Alexander F. Rosenberg2,5, Frances E. Lund2 1Dept. of Medicine, Division of Infectious Disease, 2Dept of Microbiology, 5Informatics Institute, 6Dept. of Medicine, Division of Clinical Immunology and Rheumatology and at The University of Alabama at Birmingham, Birmingham, AL 35294 USA 3Dept. of Microbiology and Immunology and 4Department of Medicine, Division of Rheumatology Emory University, Atlanta, GA 30322, USA Correspondence should be addressed to: Frances E. Lund, PhD Charles H. McCauley Professor and Chair Dept of Microbiology University of Alabama at Birmingham 276 BBRB Box 11 1720 2nd Avenue South Birmingham AL 35294-2170 [email protected] SHORT RUNNING TITLE: Effector memory B cell development after influenza vaccination 1 bioRxiv preprint doi: https://doi.org/10.1101/643973; this version posted February 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Seasonal influenza vaccination elicits hemagglutinin (HA)-specific CD27+ memory B cells (Bmem) that differ in expression of T-bet, BACH2 and TCF7.
    [Show full text]
  • Electron Transport Chain Activity Is a Predictor and Target for Venetoclax Sensitivity in Multiple Myeloma
    ARTICLE https://doi.org/10.1038/s41467-020-15051-z OPEN Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma Richa Bajpai1,7, Aditi Sharma 1,7, Abhinav Achreja2,3, Claudia L. Edgar1, Changyong Wei1, Arusha A. Siddiqa1, Vikas A. Gupta1, Shannon M. Matulis1, Samuel K. McBrayer 4, Anjali Mittal3,5, Manali Rupji 6, Benjamin G. Barwick 1, Sagar Lonial1, Ajay K. Nooka 1, Lawrence H. Boise 1, Deepak Nagrath2,3,5 & ✉ Mala Shanmugam 1 1234567890():,; The BCL-2 antagonist venetoclax is highly effective in multiple myeloma (MM) patients exhibiting the 11;14 translocation, the mechanistic basis of which is unknown. In evaluating cellular energetics and metabolism of t(11;14) and non-t(11;14) MM, we determine that venetoclax-sensitive myeloma has reduced mitochondrial respiration. Consistent with this, low electron transport chain (ETC) Complex I and Complex II activities correlate with venetoclax sensitivity. Inhibition of Complex I, using IACS-010759, an orally bioavailable Complex I inhibitor in clinical trials, as well as succinate ubiquinone reductase (SQR) activity of Complex II, using thenoyltrifluoroacetone (TTFA) or introduction of SDHC R72C mutant, independently sensitize resistant MM to venetoclax. We demonstrate that ETC inhibition increases BCL-2 dependence and the ‘primed’ state via the ATF4-BIM/NOXA axis. Further, SQR activity correlates with venetoclax sensitivity in patient samples irrespective of t(11;14) status. Use of SQR activity in a functional-biomarker informed manner may better select for MM patients responsive to venetoclax therapy. 1 Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA, USA.
    [Show full text]